Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
June 9, 2019
[Pitfall cryothermic dermatitis artefacta]
Mirjana Ziemer, Manfred Kunz, Monica Schüürmann, et al.
Wounds : a Compendium of Clinical Research and Practice
|
April 19, 2021
Erosive Pustular Dermatosis of the Scalp: Clinicopathological Correlation Leading to a Definition of Diagnostic Criteria
Robin Reschke, Sonja Grunewald, Uwe Paasch, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2021
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Robin Reschke, Jovian Yu, Blake Flood, et al.
Trends in Immunology
|
December 28, 2024
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
Robin Reschke, Ryan J Sullivan, Evan J Lipson, et al.
Cancer Immunology Research
|
August 17, 2022
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines
Robin Reschke, Jason W Shapiro, Jovian Yu, et al.
Cancers
|
August 12, 2023
Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
Felix Johnson, Benedikt Hofauer, Markus Wirth, et al.
International Journal of Molecular Sciences
|
August 7, 2021
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
Robin Reschke, Philipp Gussek, Andreas Boldt, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2024
Predictive Value of Dual-Energy CT-Derived Metrics for the Use of Bone Substitutes in Distal Radius Fracture Surgery
Philipp Reschke, Vitali Koch, Scherwin Mahmoudi, et al.
Journal for Immunotherapy of Cancer
|
January 27, 2026
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma
Robin Reschke, Petra Budde, Hans-Dieter Zucht, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2023
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
Julia-Christina Stadler, Laura Keller, Christian Mess, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|
June 9, 2019
[Pitfall cryothermic dermatitis artefacta]
Mirjana Ziemer, Manfred Kunz, Monica Schüürmann, et al.
Wounds : a Compendium of Clinical Research and Practice
|
April 19, 2021
Erosive Pustular Dermatosis of the Scalp: Clinicopathological Correlation Leading to a Definition of Diagnostic Criteria
Robin Reschke, Sonja Grunewald, Uwe Paasch, et al.
Journal for Immunotherapy of Cancer
|
October 1, 2021
Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma
Robin Reschke, Jovian Yu, Blake Flood, et al.
Trends in Immunology
|
December 28, 2024
Targeting molecular pathways to control immune checkpoint inhibitor toxicities
Robin Reschke, Ryan J Sullivan, Evan J Lipson, et al.
Cancer Immunology Research
|
August 17, 2022
Checkpoint Blockade-Induced Dermatitis and Colitis Are Dominated by Tissue-Resident Memory T Cells and Th1/Tc1 Cytokines
Robin Reschke, Jason W Shapiro, Jovian Yu, et al.
Cancers
|
August 12, 2023
Novel Discovery of the Somatostatin Receptor (SSTR2) in Pleomorphic Adenomas via Immunohistochemical Analysis of Tumors of the Salivary Glands
Felix Johnson, Benedikt Hofauer, Markus Wirth, et al.
International Journal of Molecular Sciences
|
August 7, 2021
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
Robin Reschke, Philipp Gussek, Andreas Boldt, et al.
Diagnostics (Basel, Switzerland)
|
April 13, 2024
Predictive Value of Dual-Energy CT-Derived Metrics for the Use of Bone Substitutes in Distal Radius Fracture Surgery
Philipp Reschke, Vitali Koch, Scherwin Mahmoudi, et al.
Journal for Immunotherapy of Cancer
|
January 27, 2026
Autoantibodies as predictors for immune-related adverse events in checkpoint inhibition therapy of metastatic melanoma
Robin Reschke, Petra Budde, Hans-Dieter Zucht, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2023
Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors
Julia-Christina Stadler, Laura Keller, Christian Mess, et al.
Page
of 5